These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30556836)

  • 41. Propensity Score Methods for Analyzing Observational Data Like Randomized Experiments: Challenges and Solutions for Rare Outcomes and Exposures.
    Ross ME; Kreider AR; Huang YS; Matone M; Rubin DM; Localio AR
    Am J Epidemiol; 2015 Jun; 181(12):989-95. PubMed ID: 25995287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Annals Understanding Clinical Research: Intention-to-Treat Analysis.
    Liao JM; Stack CB; Griswold ME; Localio AR
    Ann Intern Med; 2017 May; 166(9):662-664. PubMed ID: 28288485
    [No Abstract]   [Full Text] [Related]  

  • 43. Adherence adjustment in the Coronary Drug Project: A call for better per-protocol effect estimates in randomized trials.
    Murray EJ; Hernán MA
    Clin Trials; 2016 Aug; 13(4):372-8. PubMed ID: 26951361
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis.
    Fergusson D; Aaron SD; Guyatt G; Hébert P
    BMJ; 2002 Sep; 325(7365):652-4. PubMed ID: 12242181
    [No Abstract]   [Full Text] [Related]  

  • 45. Modified intention-to-treat analysis did not bias trial results.
    Dossing A; Tarp S; Furst DE; Gluud C; Wells GA; Beyene J; Hansen BB; Bliddal H; Christensen R
    J Clin Epidemiol; 2016 Apr; 72():66-74. PubMed ID: 26562052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intention to treat analysis and per protocol analysis: complementary information.
    Prescrire Int; 2012 Dec; 21(133):304-6. PubMed ID: 23373104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Good intentions and ICH-GCP: Trial conduct training needs to go beyond the ICH-GCP document and include the intention-to-treat principle.
    Browne LH; Graham PH
    Clin Trials; 2014 Dec; 11(6):629-34. PubMed ID: 25023199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intention-to-treat analysis: who is in? Who is out?
    Kruse RL; Alper BS; Reust C; Stevermer JJ; Shannon S; Williams RH
    J Fam Pract; 2002 Nov; 51(11):969-71. PubMed ID: 12485553
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy Analysis in Healthy-Volunteer Influenza Challenge Trials: Intention To Treat.
    Hunsberger S; Memoli MJ
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29269430
    [No Abstract]   [Full Text] [Related]  

  • 50. Missing data from missing participants.
    Johnson MJ; Hussain JA; Torgerson DJ; Bland MJ
    J Pain Symptom Manage; 2012 Dec; 44(6):e1-2; author reply e2-4. PubMed ID: 23102758
    [No Abstract]   [Full Text] [Related]  

  • 51. Assessing causal relationships between treatments and clinical outcomes: always read the fine print.
    Freidlin B; Korn EL
    Bone Marrow Transplant; 2012 May; 47(5):626-32. PubMed ID: 21625225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Limitations regarding double-blinding, adherence to the intention to treat principle, and postoperative dosage of paracetamol.
    Frey J; van der Linden J
    Ann Surg; 2011 Aug; 254(2):389; author reply 389-90. PubMed ID: 21694579
    [No Abstract]   [Full Text] [Related]  

  • 53. Inconsistent trial assessments by the National Institute for Health and Clinical Excellence and IQWiG: standards for the performance and interpretation of subgroup analyses are needed.
    Hasford J; Bramlage P; Koch G; Lehmacher W; Einhäupl K; Rothwell PM
    J Clin Epidemiol; 2010 Dec; 63(12):1298-304. PubMed ID: 20172690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simple Estimation of Patient-Oriented Effects From Randomized Trials: An Open and Shut CACE.
    Steele RJ; Shrier I; Kaufman JS; Platt RW
    Am J Epidemiol; 2015 Sep; 182(6):557-66. PubMed ID: 26283090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intention to treat (ITT) analysis as reported in orthodontic randomized controlled trials-evaluations of methodology and recommendations for the accurate use of ITT analysis and handling dropouts.
    Bondemark L; Abdulraheem S
    Eur J Orthod; 2018 Jul; 40(4):409-413. PubMed ID: 29069355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analyzing phase III studies in hospice/palliative care. a solution that sits between intention-to-treat and per protocol analyses: the palliative-modified ITT analysis.
    Currow DC; Plummer JL; Kutner JS; Samsa GP; Abernethy AP
    J Pain Symptom Manage; 2012 Oct; 44(4):595-603. PubMed ID: 22819439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparisons of methods for analysis of repeated binary responses with missing data.
    Frank Liu G; Zhan X
    J Biopharm Stat; 2011 May; 21(3):371-92. PubMed ID: 21442514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Negative Control Outcomes: A Tool to Detect Bias in Randomized Trials.
    Arnold BF; Ercumen A
    JAMA; 2016 Dec; 316(24):2597-2598. PubMed ID: 28027378
    [No Abstract]   [Full Text] [Related]  

  • 59. The use of the intention-to-treat principle in nursing clinical trials.
    Polit DF; Gillespie BM
    Nurs Res; 2009; 58(6):391-9. PubMed ID: 19918150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exacerbations and intent-to-treat analyses in randomised trials.
    Suissa S
    Eur Respir J; 2008 Oct; 32(4):1117-8. PubMed ID: 18827158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.